Millennium Management
ABEO icon

Millennium Management’s Abeona Therapeutics ABEO Stock Holding History

Millennium Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,100
Closed -$240K – 5806
2024
Q1 		$240K Buy
+33,100
New +$210K ﹤0.01% 5272
2018
Q1 		– Sell
-4,212
Closed -$1.67M – 3584
2017
Q4 		$1.67M Buy
+4,212
New +$1.74M ﹤0.01% 2392

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's ABEO Position: Q1 2026 in Review

Millennium Management increased its Abeona Therapeutics (ABEO) stake by 24% in Q1 2026, buying an estimated $409K and bringing the position to 425,426 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3914.

Millennium Management first reported a position in ABEO in Q1 2015 and has held it in 40 quarters since. The position peaked at $16.5M in Q2 2019. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Millennium Management held 425,426 shares of Abeona Therapeutics worth $1.91M as of Q1 2026.
  • Millennium Management bought 81,858 Abeona Therapeutics shares in Q1 2026, an estimated $409K.
  • Abeona Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3914 holding.
  • Millennium Management first reported a position in Abeona Therapeutics in Q1 2015 and has held it in 40 quarters since.
  • Millennium Management's Abeona Therapeutics position peaked at $16.5M in Q2 2019.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.